Article
Reduction of integrin alpha 4 activity through splice modulating antisense oligonucleotides
10 Sept 2019
Abstract excerpt
With recent approvals of antisense oligonucleotides as therapeutics, there is an increasing interest in expanding the application of these compounds to many other diseases. Our laboratory focuses on developing therapeutic splice modulating antisense oligonucleotides to treat diseases potentially amendable to intervention during pre-mRNA processing, and here we report the use of oligomers to down-regulate integrin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
